NaDyF4Nanoparticles as T2Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging
Citations Over TimeTop 1% of 2012 papers
Abstract
A major limitation of the commonly used clinical MRI contrast agents (CAs) suitable at lower magnetic field strengths (7 T), where next-generation MRI scanners are going. We present dysprosium nanoparticles (β-NaDyF4 NPs) as T2 CAs suitable at ultrahigh fields (9.4 T). These NPs effectively enhance T2 contrast at 9.4 T, which is 10-fold higher than the clinically used T2 CA (Resovist). Evaluation of the relaxivities at 3 and 9.4 T show that the T2 contrast enhances with an increase in NP size and field strength. Specifically, the transverse relaxivity (r2) values at 9.4 T were ∼64 times higher per NP (20.3 nm) and ∼6 times higher per Dy(3+) ion compared to that at 3 T, which is attributed to the Curie spin relaxation mechanism. These results and confirming phantom MR images demonstrate their effectiveness as T2 CAs in ultrahigh field MRIs.
Related Papers
- → Determination of cerium, gadolinium, dysprosium, erbium, and ytterbium(1966)4 cited
- → Dysprosium-Gadolinium Exchange Interactions in Gadolinium Metal(1969)4 cited
- → The Dy-Gd (Dysprosium-Gadolinium) system(1983)1 cited
- Formation of Bcc Non-Equilibrium Lanthanum, Gadolinium and Dysprosium Alloys and the Magnetic Structure of Magnesium - Beta-Gadolinium and Beta-Dysprosium(1988)
- Magnetic thermal hysteresis in dysprosium, gadolinium and gadolinium/dysprosium/gadolinium nanolayers and experimental determination of thermodynamic properties of thin film systems(2012)